Simon Glerup

[Bluefield Project @BluefieldProj]

Congratulations on this milestone @AlectorTx!

[Int Society of Nephrology @ISNkidneycare]

📖 This weekend don't miss our @Kidney_Int #ISNFridaySelection: Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome https://t.co/M4zTJcepqa

[PIR International @PIR_Intl]

We recently spoke with @SimonGlerup for BioLeaders. Simon is currently CSO, co-founder and board member of Draupnir Bio, co-founder of @TeiturTrophics, and co-founder of @muna_tx.

Visit our website to read Simon's interview. https://t.co/DYc8znZugk

[Kathrin Weyer @WeyerKathrin]

Happy to share our publication on a new role of PCSK9 in the kidneys in @Kidney_Int.

Big congratulations to shared first authors @CecilieSkeby and @SandraHummelga1, and huge thanks to all our collaborators at @AarhusUni, @HealthArhusUni, @AUHdk,#DraupnirBio!

[Kidney International @Kidney_Int]

Proprotein convertase subtilisin/kexin type 9 targets #megalin in the #kidney proximal tubule and aggravates #proteinuria in #nephroticsyndrome

https://t.co/zowyzW49ZQ

@AarhusUni @AarhusUni_int
#proximaltubule #PCSK9 #alirocumab

[Daniel Fyenbo @DFyenbo]

Very nice programme with interesting talks! Looking forward to the meeting #AUcvd 👏

@KatjaZeppenfeld @josejfuster @SimonGlerup

[Aleks Engel @AleksEngel]

Latest biotech venture creation from Novo Seeds -- Muna Therapeutics focused on neurogenerative diseases with an all-star team. https://t.co/VHQBB4biIs

[Sofinnova Partners @SofinnovaVC]

Muna Therapeutics announced the successful closing of a US$ 73 million (EUR 60 million) Series A financing round co-led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund. #biotech #vcfunding https://t.co/c9LkFCt2IM

[Novo Holdings @novoholdings]

Novo Holdings today announced the successful closing of a US$ 73 M Series A financing round in Muna Therapeutics, a private biopharmaceutical company pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases.
https://t.co/eVx6lvnSgT

[UK Dementia Research Institute @UKDRI]

🚀 Muna Therapeutics launches 🚀

UK DRI Director Prof Bart De Strooper part of team behind new company which aims to develop small molecules to repair neuronal dysfunction and resolve neuroinflammation

Read more about the today's launch 👉 https://t.co/eBmeaKsgsA

[Aarhus Universitet @AarhusUni]

Forskning fra #AarhusUni har udviklet sig til firmaet Muna Therapeutics, som netop har fået én af danmarkshistoriens største biotek-investeringer. Firmaet henter knap en halv milliard fra internationale fonde til at udvikle lægemidler mod #demens-sygdomme/ https://t.co/Ucbp5KQpAe

[Simon Glerup @SimonGlerup]

Tidligere Orphazyme-boss om ny chef-udfordring:

[Simon Glerup @SimonGlerup]

Iværksættere rejste 225 mio. kr. i oktober – nu stifter de et nyt firma med venturefond i ryggen og kendt biotekprofil i front https://t.co/nRlE9ms3I8

[FlyBase @FlyBaseDotOrg]

This partnership is an effort to increase the number of reviews submitted by Drosophila researchers & increase pAbmAbs’ usefulness to the fly community. Submitting antibody reviews is easy and takes only a few minutes; we’ve even compiled some guidelines: https://t.co/WaTXfqqk2U

[pAbmAbs @pAbmAbs]

We are proud to announce our partnership with @FlyBaseDotOrg in an effort to increase pAbmAbs’ usefulness to the fly community. No more wasting money on useless antibodies! Share your antibody experience at https://t.co/3bewbQoUyt #Antibodies #Science

[FlyBase @FlyBaseDotOrg]

FlyBase has partnered with pAbmAbs https://t.co/giH8DRbqUJ, a nonprofit resource to help researchers identify antibodies that work well or do not work well for their particular application by cataloguing both positive and negative community-submitted antibody reviews. @pAbmAbs

[Simon Glerup @SimonGlerup]

Three Health researchers receive Sapere Aude millions https://t.co/IhiqxWOkd6

[Simon Glerup @SimonGlerup]

Novo-pengetank satser milliarder på danske biotekstjerner https://t.co/RuOaPdfPAz

[Simon Glerup @SimonGlerup]

PCSK9i, changing practice in cardiology: The emerging story https://t.co/WzCzIIyP8H

[pAbmAbs @pAbmAbs]

pAbmAbs are happy to announce that we have initiated a collaboration with @StressMarq in order to promote transparency in science. Follow the link below where you can read more about the collaboration and how this will benefit you!
https://t.co/Fh1lZIvKHh